对《缓释曲马多：疼痛管理综述》的勘误
Correction to: Tapentadol Prolonged Release: A Review in Pain Management.
作者信息
Deeks Emma D
机构信息
Springer, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
出版信息
Drugs. 2019 Apr;79(5):589. doi: 10.1007/s40265-019-01102-3.
Abstract
The article Tapentadol Prolonged Release: A Review in Pain Management, written by Emma D. Deeks, was originally published Online First without open access.
摘要
艾玛·D·迪克斯撰写的《缓释他喷他多：疼痛管理综述》一文最初以在线优先形式发表，无开放获取权限。
相似文献
1
Correction to: Tapentadol Prolonged Release: A Review in Pain Management.对《缓释曲马多：疼痛管理综述》的勘误
Drugs. 2019 Apr;79(5):589. doi: 10.1007/s40265-019-01102-3.
2
Correction to: Cladribine Tablets: A Review in Relapsing MS.《克拉屈滨片：复发型多发性硬化症综述》勘误
CNS Drugs. 2019 Feb;33(2):193. doi: 10.1007/s40263-019-00604-8.
3
Correction to: Sarecycline: First Global Approval.对《Sarecycline：首次全球获批》的勘误
Drugs. 2019 May;79(7):795. doi: 10.1007/s40265-019-01122-z.
4
Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A.对《达莫凝血因子α聚乙二醇化：A型血友病综述》的勘误
Drugs. 2019 Sep;79(13):1495. doi: 10.1007/s40265-019-01190-1.
5
Correction to: Trifluridine/Tipiracil: A Review in Metastatic Gastric Cancer.对《曲氟尿苷/替匹嘧啶：转移性胃癌综述》的更正
Drugs. 2019 Oct;79(15):1727. doi: 10.1007/s40265-019-01199-6.
6
Correction to: Polatuzumab Vedotin: First Global Approval.对《泊洛妥珠单抗：首次全球获批》的更正
Drugs. 2019 Nov;79(16):1829. doi: 10.1007/s40265-019-01214-w.
7
Correction to: GP2015: An Etanercept Biosimilar.对《GP2015：一种依那西普生物类似药》的勘误
BioDrugs. 2018 Oct;32(5):525. doi: 10.1007/s40259-018-0296-z.
8
Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.普瑞巴林治疗伴有或不伴有神经病理性疼痛成分的严重慢性腰痛的有效性和安全性：一项开放标签、3b 期研究结果。
Curr Med Res Opin. 2012 Jun;28(6):911-36. doi: 10.1185/03007995.2012.679254. Epub 2012 May 9.
9
Practical considerations for the use of tapentadol prolonged release for the management of severe chronic pain.使用缓释曲马多治疗重度慢性疼痛的实际考量
Clin Ther. 2015 Jan 1;37(1):94-113. doi: 10.1016/j.clinthera.2014.07.005. Epub 2014 Aug 6.
10
Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study.与羟考酮/纳洛酮缓释片相比，曲马多缓释片治疗伴有神经病理性成分的重度慢性下腰痛的有效性：一项随机、对照、开放标签的3b/4期研究。
Pain Pract. 2016 Jun;16(5):580-99. doi: 10.1111/papr.12308. Epub 2015 Jun 12.
引用本文的文献
1
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain.慢性疼痛患者的药物治疗与治疗药物监测
Pharmaceutics. 2023 Aug 5;15(8):2088. doi: 10.3390/pharmaceutics15082088.
Zotero 插件